QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase
- PMID: 1738151
- DOI: 10.1021/jm00081a022
QSAR analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase
Erratum in
- J Med Chem 1992 Dec 11;35(25):4767
Abstract
QSAR analyses have been performed on the substituted indanone and benzylpiperidine ring substructures of a set of acetylcholinesterase, AChE, inhibitors of which 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride is a potent in vitro and ex vivo inhibitor. The method of molecular decomposition-recomposition was used to define the sets of molecular substructures and corresponding in vitro inhibition databases. A QSAR involving the magnitude of the dipole moment, the highest occupied molecular orbital (HOMO) energy, and a specific pi-orbital wave function coefficient of the substituted indanone ring substructure was constructed and found to be significant. The absence of any molecular-shape or bulk term in the QSAR, coupled with some of the relatively large substituents used to construct the QSAR, suggests considerable space is available around the indanone ring during the inhibition process. A set of QSARs were constructed and evaluated for substituents on the aromatic ring of the benzylpiperidine substructure. The most significant QSAR involves a representation of molecular shape, the largest principal moment of inertia, and the HOMO of the substituted aromatic ring. It appears that upon binding the receptor "wall" is closely fit around the benzyl ring, especially near the para position. Overall, the QSAR analysis suggests inhibition potency can be better enhanced by substitution on the indanone ring, as compared to the aromatic sites of the benzylpiperidine ring. Moreover, inhibition potency can be rapidly diminished, presumably through steric interactions with the receptor surface of AChE, by substitution of moderate to large groups on the benzyl ring, particularly at the para position.
Similar articles
-
Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase.J Med Chem. 1992 Feb 7;35(3):590-601. doi: 10.1021/jm00081a023. J Med Chem. 1992. PMID: 1738152
-
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds.J Med Chem. 1995 Nov 24;38(24):4821-9. doi: 10.1021/jm00024a009. J Med Chem. 1995. PMID: 7490731
-
Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.Eur J Med Chem. 2017 Feb 15;127:671-690. doi: 10.1016/j.ejmech.2016.10.036. Epub 2016 Oct 20. Eur J Med Chem. 2017. PMID: 27823887
-
[Advances in search for acetylcholinesterase inhibitor based on the double active sites hypothesis].Yao Xue Xue Bao. 2002 Sep;37(9):749-52. Yao Xue Xue Bao. 2002. PMID: 12567905 Review. Chinese. No abstract available.
-
Recent developments in biological activities of indanones.Eur J Med Chem. 2017 Sep 29;138:182-198. doi: 10.1016/j.ejmech.2017.06.032. Epub 2017 Jun 21. Eur J Med Chem. 2017. PMID: 28667874 Review.
Cited by
-
Automated docking of 82 N-benzylpiperidine derivatives to mouse acetylcholinesterase and comparative molecular field analysis with 'natural' alignment.J Comput Aided Mol Des. 1999 Jul;13(4):355-71. doi: 10.1023/a:1008071118697. J Comput Aided Mol Des. 1999. PMID: 10425601
-
Synthesis of bistetrahydroquinolines as potential anticholinesterasic agents by double Diels-Alder reactions.Molecules. 2013 Oct 17;18(10):12951-65. doi: 10.3390/molecules181012951. Molecules. 2013. PMID: 24141245 Free PMC article.
-
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses.Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):7-12. doi: 10.1046/j.1365-2125.1998.0460s1007.x. Br J Clin Pharmacol. 1998. PMID: 9839759 Free PMC article. Clinical Trial.
-
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses.Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):1-6. doi: 10.1046/j.1365-2125.1998.0460s1001.x. Br J Clin Pharmacol. 1998. PMID: 9839758 Free PMC article. Clinical Trial.
-
Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses.Br J Clin Pharmacol. 1998 Nov;46 Suppl 1(Suppl 1):25-9. doi: 10.1046/j.1365-2125.1998.0460s1025.x. Br J Clin Pharmacol. 1998. PMID: 9839762 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Chemical Information
Molecular Biology Databases
Research Materials
Miscellaneous